Search research articles
Contact Us
Filters
Showing results (121-130 of 135) with videos related to
Page
of 14
Sort By:
Molecular Plant
|
February 17, 2015
A Gene Expression Profiling of Early Rice Stamen Development that Reveals Inhibition of Photosynthetic Genes by OsMADS58
Rui Chen, Li-Ping Shen, Dong-Hui Wang, et al.
Nature Communications
|
January 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, et al.
Acta Pharmaceutica Sinica. B
|
March 5, 2025
Dimeric natural product panepocyclinol A inhibits STAT3 <i>via</i> di-covalent modification
Li Li, Yuezhou Wang, Yiqiu Wang, et al.
Cancer Research
|
October 21, 2016
Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors
Jie Jiang, Fu Gui, Zhixiang He, et al.
The Journal of Clinical Investigation
|
September 25, 2019
Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H
Fu Gui, Yuebo Zhang, Jianhua Wan, et al.
Annals of Nuclear Medicine
|
December 25, 2023
Impact of preoperative [<sup>18</sup>F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study
Jun-Tao Lin, Xiang-Meng Li, Wen-Zhao Zhong, et al.
JAMA Oncology
|
August 14, 2020
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial
Ke-Da Yu, Fu-Gui Ye, Min He, et al.
EMBO Molecular Medicine
|
November 30, 2021
A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC
Yue Lu, Zhenzhen Fan, Su-Jie Zhu, et al.
Brain : a Journal of Neurology
|
October 24, 2024
Radiosurgery versus observation for brainstem cavernous malformations: a 5-year multicentre cohort study
Da Li, Jian-Cong Weng, Shi-Bin Sun, et al.
Molecular Cancer
|
December 20, 2025
Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial)
Xi-Yu Liu, Xin-Yi Sui, Ying Xu, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 135) with videos related to
Sort By:
Page
of 14
Molecular Plant
|
February 17, 2015
A Gene Expression Profiling of Early Rice Stamen Development that Reveals Inhibition of Photosynthetic Genes by OsMADS58
Rui Chen, Li-Ping Shen, Dong-Hui Wang, et al.
Nature Communications
|
January 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, et al.
Acta Pharmaceutica Sinica. B
|
March 5, 2025
Dimeric natural product panepocyclinol A inhibits STAT3 <i>via</i> di-covalent modification
Li Li, Yuezhou Wang, Yiqiu Wang, et al.
Cancer Research
|
October 21, 2016
Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors
Jie Jiang, Fu Gui, Zhixiang He, et al.
The Journal of Clinical Investigation
|
September 25, 2019
Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H
Fu Gui, Yuebo Zhang, Jianhua Wan, et al.
Annals of Nuclear Medicine
|
December 25, 2023
Impact of preoperative [<sup>18</sup>F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study
Jun-Tao Lin, Xiang-Meng Li, Wen-Zhao Zhong, et al.
JAMA Oncology
|
August 14, 2020
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial
Ke-Da Yu, Fu-Gui Ye, Min He, et al.
EMBO Molecular Medicine
|
November 30, 2021
A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC
Yue Lu, Zhenzhen Fan, Su-Jie Zhu, et al.
Brain : a Journal of Neurology
|
October 24, 2024
Radiosurgery versus observation for brainstem cavernous malformations: a 5-year multicentre cohort study
Da Li, Jian-Cong Weng, Shi-Bin Sun, et al.
Molecular Cancer
|
December 20, 2025
Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial)
Xi-Yu Liu, Xin-Yi Sui, Ying Xu, et al.
Page
of 14